New! Sign up for our free email newsletter.
Reference Terms
from Wikipedia, the free encyclopedia

Alzheimer's disease

Alzheimer's disease (AD), also known simply as Alzheimer's, is a neurodegenerative disease that, in its most common form, is found in people over age 65. Approximately 24 million people worldwide have dementia of which the majority (~60%) is due to Alzheimer's.

Clinical signs of Alzheimer's disease are characterized by progressive cognitive deterioration, together with declining activities of daily living and by neuropsychiatric symptoms or behavioral changes. The most striking early symptom is memory loss (amnesia), usually manifest as minor forgetfulness that becomes steadily denser with illness progression, with relative preservation of older memories.

It is the most common type of dementia. Plaques which contain misfolded peptides called amyloid beta (Aβ) are formed in the brain many years before the clinical signs of Alzheimer's are observed. Together, these plaques and neurofibrillary tangles form the pathological hallmarks of the disease. These features can only be discovered at autopsy and help to confirm the clinical diagnosis. Medications can help reduce the symptoms of the disease, but they cannot change the course of the underlying pathology.

The ultimate cause of Alzheimer's is unknown. Genetic factors are clearly indicated as evidenced by dominant mutations in three different genes have been identified that account for the small number of cases of familial, early-onset AD. For the more common form of late onset AD (LOAD), ApoE is the only clearly established susceptibility gene. All four genes can contain mutations or variants that confer increased risk for AD, but account for only 30% of the genetic picture of AD. These four genes have in common the fact that mutations in each lead to the excessive accumulation in the brain of Aβ, the main component of the senile plaques that litter the brains of AD patients.

Related Stories
 


Mind & Brain News

October 31, 2025

From mini-brains to spider-inspired gloves and wolf apple coatings, scientists are turning eerie-sounding experiments into real innovations that could revolutionize health and sustainability. Lab-grown brain organoids may replace animal testing, ...
Researchers used supramolecular nanoparticles to repair the brain’s vascular system and reverse Alzheimer’s in mice. Instead of carrying drugs, the nanoparticles themselves triggered natural clearance of amyloid-β proteins. This restored ...
People with gum disease may have higher levels of brain white matter damage, a new study finds. Researchers observed that participants with gum disease had significantly more white matter hyperintensities, even after accounting for other risk ...
New research reveals that intelligence plays a key role in how well people process speech in noisy environments. The study compared neurotypical and neurodivergent individuals and found that cognitive ability predicted performance across all groups. ...
Generalized anxiety disorder affects millions, often trapping sufferers in cycles of fear and isolation that conventional medications barely relieve. At UCSF, neuroscientist Jennifer Mitchell is testing a pharmaceutical form of LSD called MM120, ...
GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, and nicotine use. Though more research is ...
A new study shows that eating more fruits and vegetables during the day can significantly improve sleep that same night. Researchers found a clear link between diet quality and sleep depth, with participants who met the CDC’s daily produce ...
Researchers found that neurons can use fat, not just sugar, to power the brain. When a protein called DDHD2 fails, this process breaks down and leads to serious brain problems. Scientists were able to restore damaged cells by feeding them fatty ...
Inside your body, an intricate communication network constantly monitors breathing, heart rate, digestion, and immune function — a hidden “sixth sense” called interoception. Now, Nobel laureate ...
A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The research simulated the effects of cholesterol-lowering drugs and showed up to an 80% lower risk for certain genetic profiles. ...
Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ultra-sensitive ASA-PD imaging method, they captured these clusters in brain tissue, finding larger and more numerous ...
Cedars-Sinai researchers created “young” immune cells from human stem cells that reversed cognitive decline and Alzheimer’s symptoms in mice. The treated animals showed better memory and healthier brain structures. The cells seemed to protect ...

Latest Headlines

updated 12:56 pm ET